Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung
- PMID: 11745231
- DOI: 10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h
Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung
Abstract
Background: The majority of lung carcinoma cases occur in current or former smokers. K-ras gene mutations are common in lung adenocarcinoma and have been associated with cigarette smoking, asbestos exposure, and female gender.
Methods: In the current study, the authors examined the contribution of cigarette smoking to K-ras gene mutations in patients with primary lung adenocarcinoma. Smoking histories were obtained from 106 prospectively enrolled patients with primary adenocarcinoma of the lung.
Results: K-ras mutations were detected in the primary tumor using an allele-specific ligation assay. Ninety-two of the 106 patients (87%) with lung adenocarcinoma were smokers. Nonsmokers with this tumor were more likely to be women (11 of 14; 79%), whereas the majority of smokers (57%) were men. K-ras mutations were detected in 40 of 106 tumors (38%) and were significantly more common in smokers compared with nonsmokers (43% vs. 0%; P = 0.001).
Conclusions: The results of the current study confirm and extend previous observations that smokers with adenocarcinoma of the lung are more likely to have K-ras mutant tumors compared with nonsmokers. The strong link between cigarette smoking and K-ras mutations in adenocarcinoma of the lung supports the role of specific tobacco carcinogens in the etiology of this malignancy.
Copyright 2001 American Cancer Society.
Similar articles
-
Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10207632
-
K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.Cancer. 1993 Jul 15;72(2):432-8. doi: 10.1002/1097-0142(19930715)72:2<432::aid-cncr2820720219>3.0.co;2-#. Cancer. 1993. PMID: 8319174
-
Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.Am J Respir Cell Mol Biol. 1999 Apr;20(4):667-74. doi: 10.1165/ajrcmb.20.4.3404. Am J Respir Cell Mol Biol. 1999. PMID: 10100998
-
Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes.Mutat Res. 2009 Sep-Dec;682(2-3):83-93. doi: 10.1016/j.mrrev.2009.07.003. Epub 2009 Aug 3. Mutat Res. 2009. PMID: 19651236 Review.
-
Clinical significance of ras oncogene activation in human lung cancer.Cancer Res. 1992 May 1;52(9 Suppl):2665s-2669s. Cancer Res. 1992. PMID: 1562997 Review.
Cited by
-
Associations between hyperglycaemia and somatic transversion mutations in mitochondrial DNA of people with diabetes mellitus.Diabetologia. 2003 Nov;46(11):1559-66. doi: 10.1007/s00125-003-1215-4. Epub 2003 Oct 7. Diabetologia. 2003. PMID: 14530862
-
Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments.Oncoimmunology. 2018 Jul 30;7(10):e1494677. doi: 10.1080/2162402X.2018.1494677. eCollection 2018. Oncoimmunology. 2018. PMID: 30288364 Free PMC article.
-
Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists.J Clin Med. 2018 Jul 31;7(8):192. doi: 10.3390/jcm7080192. J Clin Med. 2018. PMID: 30065223 Free PMC article. Review.
-
Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.Gen Thorac Cardiovasc Surg. 2008 Mar;56(3):97-103. doi: 10.1007/s11748-007-0193-8. Epub 2008 Mar 14. Gen Thorac Cardiovasc Surg. 2008. PMID: 18340507 Review.
-
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.J Thorac Oncol. 2008 Sep;3(9):1003-11. doi: 10.1097/JTO.0b013e31818396a4. J Thorac Oncol. 2008. PMID: 18758303 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous